LY2127399

dacetuzumab · Wyeth

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY2127399, covering 2015-06-29 to 2018-06-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2127399 in Participants With Systemic Lupus Erythematosus [Phase 3]